Inventor
Brian D. Klein
Inventor
Potomac, MD, US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations44%
A61KPreparations for medical, dental or toiletry purposes33%
C07DHeterocyclic compounds11%
C07KPeptides11%
PatentTitleYear
11,103,506Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use202110,537,573Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use202010,172,909Neuropeptide analogs, compositions, and methods for treating pain20197,897,636'Sulfamide derivative useful for the treatment of epilepsy'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2021Patents assigned to JANSSEN PHARMACEUTICA NV (3)· patent assignee history
2011–2019Based in Salt Lake City, UT, US· patent location history
2019Patents assigned to NEUROADJUVANTS INC (1)· patent assignee history
2019Patents assigned to THE UNIV OF UTAH RESEARCH FOUNDATION (1)· patent assignee history
2020–2021Based in Potomac, MD, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 3 | 2011–2021 |
| NEUROADJUVANTS INC | 1 | 2019 |
| THE UNIV OF UTAH RESEARCH FOUNDATION | 1 | 2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Potomac, Maryland, US | 2 | 2020–2021 |
| Salt Lake City, UT, US | 2 | 2011–2019 |